Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	D(1A) dopamine receptor
Species	Homo sapiens (Human)
Gene	DRD1
Synonym	D1 receptor D1A DADR Gpcr15 dopamine D1 receptor Dopamine-1A receptor [ Show all ]
Disease	Unspecified Hypertension Pain Parkinson's disease Psychiatric disorder Psychotic disorders Schizophrenia Substance dependence Type 2 diabetes Excessive bleeding following childbirth and spontaneous or elective abortion Cocaine addiction Dementia Cognitive disorders [ Show all ]
Length	446
Amino acid sequence	MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIPVAIMIVTYTRIYRIAQKQIRRIAALERAAVHAKNCQTTTGNGKPVECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCGSGETQPFCIDSNTFDVFVWFGWANSSLNPIIYAFNADFRKAFSTLLGCYRLCPATNNAIETVSINNNGAAMFSSHHEPRGSISKECNLVYLIPHAVGSSEDLKKEEAAGIARPLEKLSPALSVILDYDTDVSLEKIQPITQNGQHPT
UniProt	P21728
Protein Data Bank	N/A
GPCR-HGmod model	P21728
3D structure model	This predicted structure model is from GPCR-EXP P21728.
BioLiP	N/A
Therapeutic Target Database	T22118
ChEMBL	CHEMBL2056
IUPHAR	214
DrugBank	BE0000020

Ligand

Name	ondansetron
Molecular formula	C18H19N3O
IUPAC name	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
Molecular weight	293.37
Hydrogen bond acceptor	2
Hydrogen bond donor	0
XlogP	2.3
Synonyms	39O049 KS-00000JSZ 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one NC00706 AB00373674-15 ACT02589 Ondansetron, (+,-)-Isomer BCP28911 Prestwick3_001058 BSPBio_001016 SC-07554 CHEMBL46 ST2412612 DESMETHYLONDANSETRON GR 38032X 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one HMS3259H08 Zofran HY-B0002B 9-Methyl-3- (2-methyl-imidazol-1ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one LS-172305 99614-01-4 NCGC00179341-07 AB00373674_19 ondansetron (Zofran) AN-6592 PHL-ondansetron BPBio1_001118 S-2116 CAS-99614-02-5 SN-307 CTK8G2184 TL8006071 DSSTox_RID_77011 (RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one GR-38032F/GR-38032 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one Zofran ODT 108303-49-7 I544 9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one MLS006011928 AB0013753 NSC_68647 AC1L1IIM Ondansetron [USAN:INN:BAN] BBL010304 Prestwick1_001058 BRD-A19736161-003-03-0 Sandoz ondansetron CHEBI:7773 SR-01000763250-4 FT-0631004 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one GTPL2290 VA11441 Zudan HMS3371E18 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- KS-5227 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one NCGC00179341-02 AB00373674-17 Ondansetron (base and/or unspecified salts) AKOS000599484 Oprea1_435466 BCP9001025 QC-660 C07325 SCHEMBL4542 CPD001307702 STK370548 DSSTox_CID_3393 GR-38032 1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1yl)methyl]-4H-carbazol-4-one Zofran (TN) I06-0687 9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one LS-51878 99614-01-4 (mono-hydrochloride) NCI60_022780 AB2000413 ONDANSETRON HCl Apo-ondansetron PMS-ondansetron BR-29654 s1996 CAS_68647 SPBio_002938 D00456 Tox21_113048 DTXSID8023393 1,2,3,4-Tetrahydro-9-methyl-3-(2-methyl-1H-imidazol-1-ylmethyl)carbazol-4-one GR38032 103639-04-9 Zofran ODT (TN) 116002-70-1 KB-308401 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one MolPort-001-944-253 AB00373674 Odansetron [common misspelling of ondansetron] ACN-049703 Ondansetron [USP:INN:BAN] BC220610 Prestwick2_001058 BRN 3622981 SBB066158 ST077669 DB00904 GR 38032 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H- carbazol-4-one HMS2090H16 Z1741971217 Zuplenz HSDB 8304 L000456 9-methyl-3-[(2-methylimidazolyl)methyl]-1,2,3,9-tetrahydro-4aH-carbazol-4-one NCGC00179341-04 AB00373674_18 Ondansetron (JAN/USP/INN) AKOS016340526 Oprea1_852372 BDBM85330 Ratio-ondansetron C18H19N3O SMR001307702 CS-2393 TimTec1_001750 DSSTox_GSID_23393 GR-38032F 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1 -yl)methyl]-4H-carbazol-4-one ZOFRAN IN PLASTIC CONTAINER 103639-04-9 (mono-hydrochloride dihydrate) I06-1329 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one MCULE-9438746800 99614-02-5 Novo-ondansetron AC-28927 Ondansetron Injection BAS 00717177 Prestwick0_001058 BRD-A19736161-001-01-8 SAM002589958 CBDivE_008994 SR-01000763250 D0K7WK Tox21_113048_1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 1,2,3,9,-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one GR38032F Zophren [ Show all ]
Inchi Key	FELGMEQIXOGIFQ-UHFFFAOYSA-N
Inchi ID	InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3
PubChem CID	4595
ChEMBL	CHEMBL46
IUPHAR	N/A
BindingDB	85330
DrugBank	DB00904
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
Ki	<10000.0 nM	PMID9686407	BindingDB

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417